These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28007586)

  • 1. Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.
    Volk DW
    Neurobiol Dis; 2017 Mar; 99():58-65. PubMed ID: 28007586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia.
    Kolluri N; Sun Z; Sampson AR; Lewis DA
    Am J Psychiatry; 2005 Jun; 162(6):1200-2. PubMed ID: 15930070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia.
    Hoftman GD; Datta D; Lewis DA
    Biol Psychiatry; 2017 May; 81(10):862-873. PubMed ID: 27455897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.
    Lewis DA; Pierri JN; Volk DW; Melchitzky DS; Woo TU
    Biol Psychiatry; 1999 Sep; 46(5):616-26. PubMed ID: 10472415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
    Broadbelt K; Jones LB
    J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia.
    Volk DW; Pierri JN; Fritschy JM; Auh S; Sampson AR; Lewis DA
    Cereb Cortex; 2002 Oct; 12(10):1063-70. PubMed ID: 12217970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons.
    Lewis DA; Glantz LA; Pierri JN; Sweet RA
    Ann N Y Acad Sci; 2003 Nov; 1003():102-12. PubMed ID: 14684438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profile associated with postnatal development of pyramidal neurons in the human prefrontal cortex implicates ubiquitin ligase E3 in the pathophysiology of schizophrenia onset.
    Kohlbrenner EA; Shaskan N; Pietersen CY; Sonntag KC; Woo TW
    J Psychiatr Res; 2018 Jul; 102():110-117. PubMed ID: 29635114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia.
    Mallya AP; Deutch AY
    Schizophr Bull; 2018 Aug; 44(5):948-957. PubMed ID: 30124942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia.
    Lewis DA; Gonzalez-Burgos G
    Brain Res Bull; 2000 Jul; 52(5):309-17. PubMed ID: 10922508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.
    Arion D; Corradi JP; Tang S; Datta D; Boothe F; He A; Cacace AM; Zaczek R; Albright CF; Tseng G; Lewis DA
    Mol Psychiatry; 2015 Nov; 20(11):1397-405. PubMed ID: 25560755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of microglial markers of phagocytosis in schizophrenia.
    Jenkins AK; Lewis DA; Volk DW
    Schizophr Res; 2023 Jan; 251():22-29. PubMed ID: 36527956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
    Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.
    Datta D; Arion D; Corradi JP; Lewis DA
    Biol Psychiatry; 2015 Dec; 78(11):775-85. PubMed ID: 25981171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological, structural, and functional alterations of the prefrontal cortex and the basolateral amygdala after early lesion of the rat mediodorsal thalamus.
    Ouhaz Z; Ba-M'hamed S; Bennis M
    Brain Struct Funct; 2017 Aug; 222(6):2527-2545. PubMed ID: 28150086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons.
    Lewis DA; Hashimoto T
    Int Rev Neurobiol; 2007; 78():109-31. PubMed ID: 17349859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.
    Pierri JN; Chaudry AS; Woo TU; Lewis DA
    Am J Psychiatry; 1999 Nov; 156(11):1709-19. PubMed ID: 10553733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing alterations in excitation and inhibition of layer 5 medial prefrontal cortex pyramidal neurons following neonatal ventral hippocampal lesion.
    Ryan RT; Bhardwaj SK; Tse YC; Srivastava LK; Wong TP
    Cereb Cortex; 2013 May; 23(5):1198-207. PubMed ID: 22581849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.
    Konopaske GT; Balu DT; Presti KT; Chan G; Benes FM; Coyle JT
    Schizophr Res; 2018 Nov; 201():270-277. PubMed ID: 29759351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.
    Lewis DA; Volk DW; Hashimoto T
    Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.